Remove 2017 Remove Access Remove Programs
article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Studies: Medical Cannabis Enrollees Typically Reduce Their Use of Opioids

NORML

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. These conclusions are hardly unique. percent versus 44.8

article thumbnail

Patients Frequently Substituting Cannabis For Anti-Anxiety Drugs

NORML

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.

Patients 237
article thumbnail

Study: Daily Cannabis Use Among Pain Patients Associated with Less Non-Prescription Opioid Use

NORML

A team of investigators from Canada and the United States assessed drug use trends in chronic pain patients over a multi-year period (June 1, 2014 to December 1, 2017). Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

article thumbnail

The Latin American Cannabis Landscape – Part Two: Regulated Markets and Patient Access

CannaTech

Medical cannabis continued to pop up across the region year after year: imports in Brazil began in 2014, trials started in Chile in 2014, regulations were implemented in Colombia and Jamaica in 2015, the same followed in the Cayman Islands and parts of Argentina in 2016, Paraguay in 2017, and the list carries on from 2018 to date.

Access 89
article thumbnail

Weekly Legislative Roundup 2/1/19

NORML

Legislation has been reintroduced from last year, Senate Bill 34, which would exempt compassionate care programs from paying state cannabis taxes when they are providing free medical cannabis to financially disadvantaged people living with serious health conditions. Click here to email your lawmakers in support of banking access.